The review considers the role of selenium in the pathogenesis and therapy of thyroid diseases, including autoimmune thyroiditis, Graves' disease, hypothyroidism, and endemic goiter. Selenium is an essential microelement involved in the antioxidant protection of thyrocytes and regulation of thyroid hormone metabolism. The data on the mechanisms of selenium action, forms of metabolism, and levels of its evidence-based effectiveness in the treatment of autoimmune thyroid diseases are summarized. The results of clinical and experimental studies with differentiation by level of evidence (A-C) are presented. It has been established that in autoimmune thyroiditis, selenium can reduce antibody titers and improve the clinical condition, while in Graves' disease its effectiveness remains controversial. The importance of an individual approach to therapy, taking into account the initial level of selenium in the body, is emphasized. Conclusions are formulated that confirm the need for further research to optimize the strategy of selenium use in endocrine practice